SIXTH AMENDMENT TO 2005
CREDIT FACILITY
THIS SIXTH AMENDMENT TO 2005 CREDIT FACILITY
AGREEMENT (this " Amendment ") is made as of March
21, 2007, by and among Calypte Biomedical Corporation, a Delaware
corporation (" Issuer "), and Marr Technologies,
BV, a limited liability company established in the Netherlands ("
Purchaser "). Unless otherwise defined herein, all
capitalized terms used herein shall have the meanings given to them
in the Credit Facility referred to below.
WHEREAS, Issuer and Purchaser are parties to the
2005 Credit Facility Agreement dated as of April 4, 2005, Amendment
to 2005 Credit Facility dated as of November 30, 2005, Second
Amendment to 2005 Credit Facility dated as of February 22, 2006,
Third Amendment to 2005 Credit Facility dated as of July 6, 2006,
Fourth Amendment to 2005 Credit Facility dated as of December 22,
2006 and Fifth Amendment to 2005 Credit Facility dated as of
February 6, 2007 (collectively, the " Credit
Facility "); and
WHEREAS, the parties now desire to amend and
modify the Credit Facility to provide for the extension of the
maturity date for monies borrowed and certain other modifications
and amendments agreed to by the parties.
NOW, THEREFORE, for good and valuable
consideration, the receipt and sufficiency of which are hereby
acknowledged, Issuer and Purchaser agree as follows:
1.
Section III.b. of the Credit
Facility is hereby amended and restated to read in its entirety as
follows:
"b.
Expiration of
Agreement . This
Agreement shall t
